Dedicated to Research Since 1993
  •  

    info@genesismarketinsights.com

Biologics Safety Testing Market By Products and Services (Kits & Reagents, Services, Instruments) By Test Type (Endotoxin Tests, Sterility Tests, Cell Line Authentication and Characterization, Bioburden Tests) – Business Overview, Analysis and Industry Forecast 2017-2023

 Healthcare and Pharmaceuticals

Report Overview

GLOBAL BIOLOGICS SAFETY TESTING MARKET was valued at USD 2.79 Billion in the year 2017. Global Biologics Safety Testing market is further estimated to grow at a CAGR of 12.32% from 2018 to reach USD 5.6 Billion by the year 2023. North America region holds the highest market share in 2017 and Asia Pacific market is considered as the fastest growing market in the forecasted period. At a country level, the U.S and Canada are projected to grow strongly in the coming years.

Sigma Aldrich Corporation (U.S), Lonza group (Switzerland), SGS SA (Switzerland), Merck KGaA (Germany), Intertek (U.K), Charles River Laboratories International, Inc. (U.K), WuXi PharmaTech (China), BSL Bioservice (Germany), Cytovance Biologics, Inc. (U.S) and Toxikon Corporation (U.S) are some of the key players in the Biologics Safety Testing Market. Rising research and development expenses to address the changing demand of end users. Similarly, growth strategies such as acquisition, merger, and expansion of the distribution network were few techniques adopted by most of the top players in the last 5 years.

Drivers:

            Increasing research and investments in the healthcare industry

Restraints:

            Time consuming approval process

Opportunities:

            Technological advancements

            Pharmaceutical emerging market

Challenges:

            Availability of skilled labors

The Global Biologics Safety Testing is segmented as by products & Services, by Test Type, by application, and by region. On the basis of products & services, the market is segmented as Kits & Reagents, Services, and Instruments of which Kits & Reagents holds the highest market share. On the basis of test type the global market is segmented as Endotoxin Tests, Sterility Tests, Cell Line Authentication and Characterization Tests, Bioburden Tests, Residual Host Contaminant Detection Tests, Adventitious Agent Detection Tests and other tests of which Endotoxin Tests expected to hold the highest market share in the forecasted period.

On the other hand, by application the market is segmented as Vaccine & Therapeutics Development, Blood and Blood-Related Products Testing, Cellular and Gene Therapy, Tissue and Tissue-Related Products Testing and Stem Cell Research for this market Vaccine & Therapeutics Development is expected to grow at highest CAGR during the year 2018-2023.

Key Benefits for Stakeholders

Biologics Safety Testing manufacturers & distributors

Pharmaceutical & Biotech Research organizations and associations

Various Research organizations and consulting firms

The government, Regulatory bodies, and consumers

By Products and Services

Kits & Reagents

Services

Instruments

By Test Type

Endotoxin Tests

Sterility Tests

Cell Line Authentication and Characterization Tests

Bioburden Tests

Residual Host Contaminant Detection Tests

Adventitious Agent Detection Tests

Other tests

By Applications

Vaccine & Therapeutics Development

Blood and Blood-Related Products Testing

Cellular and Gene Therapy

Tissue and Tissue-Related Products Testing

Stem Cell Research

By Region

North America

Europe

Asia-Pacific

RoW

Key Market Players

Sigma Aldrich Corporation

Lonza group

SGS

Merck

Intertek

Charles River Laboratories International, Inc.

WuXi PharmaTech

BSL Bioservice

Cytovance Biologics, Inc.

Toxikon Corporation

(Another brief information of 10 companies will be provided in the report)

Research Methodology:

Genesis Market Insights follows in-depth Research Methodology focused on reducing deviation in the collected data. GMI offers the most precise evaluations and projection for the market numbers. GMI engages following Market Engineering techniques –

  1.      Raw Market Data is collected and compared with the Existing in-house Data on a broad front.
  2.      Both Bottom-Up and Top-Down approaches are analyzed for segmenting and estimating measurable aspects of the market.
  3.      To avoid bias, we filter the collected data collected from authenticated sources.
  4.      GMI has a well proven Statistical Modeling System for estimates and forecasts.
  5.      Further, the report findings are validated with the Industry Expert Panel on face to face or telephonic interviews.
  6.      Panelists are approached from Leading Enterprises across the value chain including manufacturers, suppliers, technology providers, domain experts and buyers so as to validate a thorough and balanced market overview.

Detailed customization is also available for you. Further, if the report listed above does not meet your key requirements. Our customized research report will analytically cover the required market information you need which will help you to plan your business decisions.

Table Of Content

1. Introduction

1.1 Market Vision

       1.1.1 Market Definition

       1.1.2 Market Scope

1.2 Limitations

1.3 Stakeholders

2. Research Methodology

2.1. Research Process

       2.1.1. Secondary Research

             2.1.1.1. Key Data from Secondary Research

       2.1.2. Primary Research

             2.1.2.1. Key Data from Primary Research

             2.1.2.2. Breakdowns of Primary Interviews

2.2. Market Size Estimation

       2.2.1. Bottoms-Up Approach

       2.2.2. Top-Down Approach

       2.2.3. Annual Revenue Process

2.3. Data Triangulation 

2.4. Research Assumptions 

       2.4.1. Assumption

3. Executive Summary

4. Market Overview

4.1. Introduction

4.2. Drivers

4.3. Restraints

4.4. Opportunities

4.5. Challenges

4.6. Regulations

4.7. Supply Chain/Value Chain Analysis

4.8. Patent & Standards

5. Industry Trends

5.1. Introduction

5.2. Porter’s Five Forces Analysis

       5.2.1. Threat of New Entrants

       5.2.2. Threat of Substitutes

       5.2.3. Bargaining Power of Buyers

       5.2.4. Bargaining Power of Suppliers

       5.2.5. Intensity of Competitive Rivalry

6. Biologics Safety Testing Market, By Products and Services

6.1 Kits & Reagents

6.2 Services

6.3 Instruments

7. Biologics Safety Testing Market, By Test Type

7.1 Endotoxin Tests

7.2 Sterility Tests

7.3 Cell Line Authentication and Characterization Tests

7.4 Bioburden Tests

7.5 Residual Host Contaminant Detection Tests

7.6 Adventitious Agent Detection Tests

7.7 Other tests

8. Biologics Safety Testing Market, By Applications

8.1 Vaccine & Therapeutics Development

8.2 Blood and Blood-Related Products Testing

8.3 Cellular and Gene Therapy

8.4 Tissue and Tissue-Related Products Testing

8.5 Stem Cell Research

9. Geographical Analysis

9.1. Introduction

9.2. North America

       9.2.1. U.S.

       9.2.2. Canada

       9.2.3. Mexico

9.3. Europe

       9.3.1. U.K.

       9.3.2. Germany

       9.3.3. France

       9.3.4. RoE

9.4. Asia Pacific

       9.4.1. China

       9.4.2. Malaysia

       9.4.3. South Korea

       9.4.4. India

            9.4.5 Ro APAC

9.5. RoW

       9.5.1. Latin America

       9.5.2. Middle East and Africa

10. Company Profiles

(Business Overview, Financial Overview, Product write Up, Recent Developments)

10.1 Sigma Aldrich Corporation

10.2 Lonza group

10.3 SGS

10.4 Merck

10.5 Intertek

10.6 Charles River Laboratories International, Inc.

10.7 WuXi PharmaTech

10.8 BSL Bioservice

10.9 Cytovance Biologics, Inc.

10.10 Toxikon Corporation

(A brief overview of 10 companies is also provided.)

11. Competitive Analysis

11.1. Introduction

11.2. Market Positioning of Key Players

11.3 Competitive Strategies Adopted by Leading Players

        11.3.1. Investments & Expansions

        11.3.2. New Product Launches

        11.3.3. Mergers & Acquisitions

        11.3.4. Agreements, Joint Ventures, and Partnerships

12. Appendix

12.1. Questionnaire

12.2. Available Customizations 

12.3. Upcoming Events (Trade Fair, Exhibitions, Conferences)

 

List of Tables (66 Tables)

Table 1 Biologics Safety Testing Market Summary
Table 2 Market, By Product and Service, 2018-2023(USD Million)
Table 3 Biologics Safety Testing Kits and Reagents Market, By Region, 2018-2023(USD Million)
Table 4 Biologics Safety Testing Services Market, By Region, 2018-2023(USD Million)
Table 5 Biologics Safety Testing Instruments Market, By Region, 2018-2023(USD Million)
Table 6 Market Size, By Test Type, 2018-2023(USD Million)
Table 7 Endotoxin Tests Market, By Region, 2018-2023(USD Million)
Table 8 Sterility Tests Market, By Region, 2018-2023(USD Million)
Table 9 Cell Line Authentication and Characterization Tests Market, By Region, 2018-2023(USD Million)
Table 10 Bioburden Tests Market, By Region, 2018-2023(USD Million)
Table 11 Residual Host Contaminant Detection Tests Market, By Region, 2018-2023(USD Million)
Table 12 Adventitious Agent Detection Tests Market, By Region, 2018-2023(USD Million)
Table 13 Other Biologics Safety Tests Market, By Region, 2018-2023(USD Million)
Table 14 Biologics Safety Testing Market, By Application, 2018-2023(USD Million)
Table 15 Market for Vaccine and Therapeutics Development, By Region, 2018-2023(USD Million)
Table 16 Market for Blood and Blood-Related Products Testing, By Region, 2018-2023(USD Million)
Table 17 Market for Cellular and Gene Therapy Products, By Region, 2018-2023(USD Million)
Table 18 Market for Tissue and Tissue-Related Products Testing, By Region, 2018-2023(USD Million)
Table 19 Market for Stem Cell Research, By Region, 2018-2023(USD Million)
Table 20 Market, By Region, 2018-2023(USD Million)
Table 21 North America: Biologics Safety Testing Market, By Country, 2018-2023(USD Million)
Table 22 North America: Market, By Application, 2018-2023(USD Million)
Table 23 North America: Market, By Product & Service, 2018-2023(USD Million)
Table 24 North America: Market, By Test Type, 2018-2023(USD Million)
Table 25 U.S.: Market, By Application, 2018-2023(USD Million)
Table 26 U.S.: Market, By Product & Service, 2018-2023(USD Million)
Table 27 Canada: Biologics Safety Testing Market, By Application, 2018-2023(USD Million)
Table 28 Canada: Market, By Product & Service, 2018-2023(USD Million)
Table 29 Europe: Market, By Country, 2018-2023(USD Million)
Table 30 Europe: Market, By Application, 2018-2023(USD Million)
Table 31 Europe: Market, By Product & Service, 2018-2023(USD Million)
Table 32 Europe: Market, By Test Type, 2018-2023(USD Million)
Table 33 Germany: Biologics Safety Testing Market, By Application, 2018-2023(USD Million)
Table 34 Germany: Market, By Product & Service, 2018-2023(USD Million)
Table 35 U.K.: Market, By Application, 2018-2023(USD Million)
Table 36 U.K.: Market, By Product & Service, 2018-2023(USD Million)
Table 37 France: Biologics Safety Testing Market, By Application, 2018-2023(USD Million)
Table 38 France: Market, By Product & Service, 2018-2023(USD Million)
Table 39 Italy: Market, By Application, 2018-2023(USD Million)
Table 40 Italy: Market, By Product & Service, 2018-2023(USD Million)
Table 41 Spain: Market, By Application, 2018-2023(USD Million)
Table 42 Spain: Market, By Product & Service, 2018-2023(USD Million)
Table 43 RoE: Biologics Safety Testing Market, By Application, 2018-2023(USD Million)
Table 44 RoE: Market, By Product & Service, 2018-2023(USD Million)
Table 45 Asia: Market, By Country, 2018-2023(USD Million)
Table 46 Asia: Market, By Application, 2018-2023(USD Million)
Table 47 Asia: Market, By Product & Service, 2018-2023(USD Million)
Table 48 Asia: Market, By Test Type, 2018-2023(USD Million)
Table 49 China: Biologics Safety Testing Market, By Application, 2018-2023(USD Million)
Table 50 China: Market, By Product & Service, 2018-2023(USD Million)
Table 51 Japan: Market, By Application, 2018-2023(USD Million)
Table 52 Japan: Market, By Product & Service, 2018-2023(USD Million)
Table 53 India: Biologics Safety Testing Market, By Application, 2018-2023(USD Million)
Table 54 India: Market, By Product & Service, 2018-2023(USD Million)
Table 55 Rest of Asia: Market, By Application, 2018-2023(USD Million)
Table 56 Rest of Asia: Market, By Product & Service, 2018-2023(USD Million)
Table 57 RoW: Biologics Safety Testing Market, By Region, 2018-2023(USD Million)
Table 58 RoW: Market, By Application, 2018-2023(USD Million)
Table 59 RoW: Market, By Product & Service, 2018-2023(USD Million)
Table 60 RoW: Market, By Test Type, 2018-2023(USD Million)
Table 61 South America, Central America, & the Caribbean: Market, By Application, 2018-2023(USD Million)
Table 62 South America, Central America, & the Caribbean: Market, By Product & Service, 2018-2023(USD Million)
Table 63 Pacific and Oceania: Biologics Safety Testing Market, By Application, 2018-2023(USD Million)
Table 64 Pacific and Oceania: Market, By Product & Service, 2018-2023(USD Million)
Table 65 Africa: Market, By Application, 2018-2023(USD Million)
Table 66 Africa: Market, By Product & Service, 2018-2023(USD Million)


List of Figures (27 Figures)

Figure 1 Research Design
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Market Size Estimation Methodology: Bottom-Up Approach
Figure 4 Market Size Estimation Methodology: Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Biologics Safety Testing Market Size, By Product & Service, 2018 vs 2023 (USD Million)
Figure 7 Global Market Size, By Application, 208 vs 2023 (USD Million)
Figure 8 Global Market Size, By Test Type, 2018 vs 2023(USD Million)
Figure 9 Global Market Size, By Region, 2018 vs 2023(USD Million)
Figure 10 Global Market to Register A High, Double-Digit Growth Rate in the Forecast Period
Figure 11 Kits & Reagents Segment to Dominate the Biologics Safety Testing Market in 2018
Figure 12 Asia to Register the Highest CAGR During the Forecast Period
Figure 13 Vaccine and Therapeutics Development Will Continue to Dominate the Global Market 2023
Figure 14 Global Market: Drivers, Restraints, Opportunities, & Challenges
Figure 15 Kits & Reagents Segment to Dominate the Market During the Forecast Period
Figure 16 Endotoxin Tests Segment to Dominate the Global Market During the Forecast Period
Figure 17 Vaccine & Therapeutics Development to Dominate the Biologics Safety Testing Market During the Forecast Period
Figure 18 North America to Dominate the Global Market in 2018
Figure 19 Asia to Register the Highest CAGR During the Forecast Period (2018 –2023)
Figure 20 U.S. to Witness the Highest Growth Rate in the North American Global Market During the Forecast Period (2017–2022)
Figure 21 North America: Market Snapshot
Figure 22 Germany to Witness the Highest Growth Rate in the European Market During the Forecast Period (2017–2022)
Figure 23 Asia: Market, By Country (2018)
Figure 24 Asia: Market Snapshot
Figure 25 Rest of the World: Market, By Region (2018)
Figure 26 Market (Global) Competitive Leadership Mapping, 2018
Figure 27 Market: Market Share (2018)

Summary

No Content Available.

PURCHASE OPTIONS

ASK FOR SPECIAL PRICING

Related Reports